QL1706 Plus Lenvatinib in Previously Treated Penile Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Penile Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Kangbo Huang) · huangkb@sysucc.org.cn · 020-15622190220

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Bladder Adenocarcinoma · Bladder Clear Cell Adenocarcinoma · Bladder Mixed Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Anchorage, United States

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

HPV-Associated Cervical Carcinoma · HPV-Related Carcinoma · HPV-Related Malignancy

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Brunswick, United States · New Brunswick, United States

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Cervical Cancer · Throat Cancer · Oropharynx Cancer

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States · New Brunswick, United States

Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis

Metastatic Penile Squamous Cell Carcinoma · Stage III Penile Cancer AJCC v8 · Stage IV Penile Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Jacksonville, United States